Evaluation of interleukin-8 ?251 T/A polymorphisms in visceral leishmaniasis
dc.contributor.author | Hajilooi, M | |
dc.contributor.author | Abasi, M | |
dc.contributor.author | Bazmani, A | |
dc.contributor.author | Ahmadi, A | |
dc.contributor.author | Matini, M | |
dc.contributor.author | Solgi, G | |
dc.contributor.author | Sardarian, K | |
dc.date.accessioned | 2018-08-26T08:54:34Z | |
dc.date.available | 2018-08-26T08:54:34Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54160 | |
dc.description.abstract | Background: Interleukin (IL)-8 plays important roles in the recruitment and activation of immune cells during visceral leishmaniasis (VL). Genetic variations in IL-8 modulate the expression of IL-8 protein and may be associated with VL. This study aimed to evaluate polymorphisms at the IL-8 ?251 position in VL patients. Methods: This cross-sectional study was performed on three groups: Leishmania-seropositive patients with clinical symptoms of VL (n=91), seropositive patients without clinical symptoms (n=104), and healthy controls (n=110). Polymorphisms at the IL-8?251 position were analyzed using allele-specific polymerase chain reaction (PCR). Anti-Leishmania antibody titers were assessed by immunofluorescence. Results: IL-8?251 polymorphism was significantly associated with VL (P<0.002). The IL-8?251 T/T genotype was significantly higher in group 1 than in groups 2 and 3 (P<0.002). The validity of the data was analyzed using Hardy-Weinberg equilibrium and one-way analysis of variance (ANOVA), as well as x2 tests. Conclusions: IL-8?251 polymorphism was significantly associated with impaired immune re-sponses in VL and might be considered a risk factor for disease development. é 2015 Health Hamadan University of Medical Sciences. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Journal of Research in Health Sciences | |
dc.subject | adenine | |
dc.subject | interleukin 8 | |
dc.subject | Leishmania antibody | |
dc.subject | parasite antibody | |
dc.subject | thymine | |
dc.subject | unclassified drug | |
dc.subject | IL8 protein, human | |
dc.subject | interleukin 8 | |
dc.subject | allele | |
dc.subject | antibody titer | |
dc.subject | Article | |
dc.subject | clinical feature | |
dc.subject | controlled study | |
dc.subject | cross-sectional study | |
dc.subject | DNA polymorphism | |
dc.subject | genetic association | |
dc.subject | genetic screening | |
dc.subject | genotype | |
dc.subject | human | |
dc.subject | immunofluorescence test | |
dc.subject | major clinical study | |
dc.subject | polymerase chain reaction | |
dc.subject | symptom | |
dc.subject | validation process | |
dc.subject | visceral leishmaniasis | |
dc.subject | gene frequency | |
dc.subject | genetic predisposition | |
dc.subject | genetics | |
dc.subject | genotype | |
dc.subject | immunity | |
dc.subject | immunology | |
dc.subject | Leishmania | |
dc.subject | metabolism | |
dc.subject | parasitology | |
dc.subject | single nucleotide polymorphism | |
dc.subject | visceral leishmaniasis | |
dc.subject | Alleles | |
dc.subject | Cross-Sectional Studies | |
dc.subject | Gene Frequency | |
dc.subject | Genetic Association Studies | |
dc.subject | Genetic Predisposition to Disease | |
dc.subject | Genotype | |
dc.subject | Humans | |
dc.subject | Immunity | |
dc.subject | Interleukin-8 | |
dc.subject | Leishmania | |
dc.subject | Leishmaniasis, Visceral | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.title | Evaluation of interleukin-8 ?251 T/A polymorphisms in visceral leishmaniasis | |
dc.type | Article | |
dc.citation.volume | 15 | |
dc.citation.index | Scopus |